Literature DB >> 12106784

Structural and functional analyses of bacterial lipopolysaccharides.

Martine Caroff1, Doris Karibian, Jean Marc Cavaillon, Nicole Haeffner-Cavaillon.   

Abstract

Bacterial lipopolysaccharides (LPSs) are powerful immunomodulators in infected hosts, and may cause endotoxic shock. Most of them share a common architecture but vary considerably in structural motifs from one genus, species, and strain to another. Cells of the innate immune response recognize evolutionarily conserved LPS molecular patterns of endotoxins and structural details thereby greatly influencing their response.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12106784     DOI： 10.1016/s1286-4579(02)01612-x

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  45 in total

1.  Assessment of lipopolysaccharide microleakage at conical implant-abutment connections.

Authors:  Sönke Harder; Elgar Susanne Quabius; Lars Ossenkop; Matthias Kern
Journal:  Clin Oral Investig       Date:  2011-12-02       Impact factor: 3.573

2.  Modulation of innate immune responses with synthetic lipid A derivatives.

Authors:  Yanghui Zhang; Jidnyasa Gaekwad; Margreet A Wolfert; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2007-03-29       Impact factor: 15.419

3.  Modification of the structure of peptidoglycan is a strategy to avoid detection by nucleotide-binding oligomerization domain protein 1.

Authors:  Margreet A Wolfert; Abhijit Roychowdhury; Geert-Jan Boons
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

4.  Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression.

Authors:  Lee W Hutson; Christina L Lebonville; Meghan E Jones; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2017-01-25       Impact factor: 7.217

5.  Monoacyl lipoteichoic acid from pneumococci stimulates human cells but not mouse cells.

Authors:  Je Hak Kim; Hoseong Seo; Seung Hyun Han; Jisheng Lin; Moon-Kook Park; Uffe B S Sorensen; Moon H Nahm
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A.

Authors:  Iyarit Thaipisuttikul; Lauren E Hittle; Ramesh Chandra; Daniel Zangari; Charneal L Dixon; Teresa A Garrett; David A Rasko; Nandini Dasgupta; Samuel M Moskowitz; Lars Malmström; David R Goodlett; Samuel I Miller; Russell E Bishop; Robert K Ernst
Journal:  Mol Microbiol       Date:  2013-11-27       Impact factor: 3.501

Review 7.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

8.  Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.

Authors:  Jeppe M Larsen; Hanieh S Musavian; Tariq M Butt; Camilla Ingvorsen; Anna H Thysen; Susanne Brix
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

9.  Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog.

Authors:  Nico Marr; Alina Tirsoaga; Didier Blanot; Rachel Fernandez; Martine Caroff
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

10.  CD14 C-159T and toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients.

Authors:  Ariane Biebl; Axel Muendlein; Zhyrgal Kazakbaeva; Sigrid Heuberger; Gudrun Sonderegger; Heinz Drexel; Susanne Lau; Renate Nickel; Michael Kabesch; Burkhard Simma
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.